← Open Payments lookup

SHELLY RANCK: Open Payments

NPI 1457320954 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,382 in 46 payments from 13 companies in 2025. Trend: 2023 $845 · 2024 $1,395 · 2025 $1,382

Food & beverage: $1,382
CompanyPaymentsAmount
Madrigal Pharmaceuticals14$330
GENZYME CORPORATION5$255
Janssen Biotech, Inc.7$206
Ardelyx, Inc.3$141
Lilly USA, LLC1$122
Gilead Sciences, Inc.4$84
ABBVIE INC.3$62
Regeneron Healthcare Solutions, Inc.3$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$47
Ipsen Biopharmaceuticals, Inc1$27

Products named: REZDIFFRA, DUPIXENT, TREMFYA, IBSRELA, OMVOH, XIFAXAN, RINVOQ, IQIRVO.

Industry payments across NE — which companies pay providers there.